Why Salesforce Rose 16% in December
Key Points
Salesforce topped estimates on the bottom line and raised its guidance.
Its Agentforce AI platform is gaining traction.
2026 could be a big year for AI software stocks.
- 10 stocks we like better than Salesforce ›
Shares of Salesforce (NYSE: CRM) were among the winners last month as the software-as-a-service (SaaS) giant beat expectations on the bottom line in its third-quarter earnings report and as it raised its guidance.
Salesforce also touted strong backlog growth and the continued expansion of its Agentforce AI platform. According to data from S&P Global Market Intelligence, the stock finished the month up 16%. As you can see from the chart below, nearly all of the stock's gains came on the earnings report at the beginning of the month.
Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue »
CRM data by YCharts
Salesforce's big beat
Nearly all of Salesforce's gains last month came from its earnings report as the stock jumped 3.7% on Dec. 4 in response to the report and tacked on another 5.3% the following day as analysts cheered the move.
Salesforce's growth on the top line was relatively modest, with revenue up just 8.6% to $10.26 billion, which matched estimates. On the bottom line, adjusted earnings per share rose from $2.41 to $3.25, which beat estimates at $2.86, though that was primarily because of gains from strategic investments and losses the year before. Adjusted operating income, which may be a better reflection of profitability, rose from $3.12 billion to $3.63 billion.
Elsewhere, the company said that Agentforce and Data 360 annual recurring revenue (ARR), two strategic AI priorities, were up 114% to $1.4 billion. Remaining performance obligations (RPO), a reflection of backlog, rose 12% to $59.5 billion.
The company also raised its revenue guidance for the year to $41.45 billion-$41.55 billion, up 9%-10%, and it expects adjusted earnings per share of $3.02-$3.04 in the fourth quarter, which compared to the consensus at $3.04.
The stock traded sideways over the rest of the month, though the company did have some positive announcements, including signing a deal with Novartis for Salesforce Agentforce Life Sciences, and benefiting from an easing of broader AI headwinds.
Image source: Getty Images.
What's next for Salesforce
2026 is setting up to be another strong year for AI stocks, and it could be the biggest test yet for products like Agentforce, as attention should start to shift toward software in the AI sector.
Salesforce's overall growth rate is expected to be modest, but it can win over more investors with strong growth from Salesforce. The stock also looks affordably priced, especially compared with its big-tech peers. If it continues finding success in AI, the stock should move higher this year.
Should you buy stock in Salesforce right now?
Before you buy stock in Salesforce, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Salesforce wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $488,653!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,148,034!*
Now, it’s worth noting Stock Advisor’s total average return is 971% — a market-crushing outperformance compared to 196% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
See the 10 stocks »
*Stock Advisor returns as of January 7, 2026.
Jeremy Bowman has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Salesforce. The Motley Fool has a disclosure policy.
Recommended Articles
